Regulation and antimetastatic functions of liver-associated natural killer cells

Immunological Reviews

Volumn 174, Issue , 2000, Pages 63-76

  Wiltrout, Robert H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; CD3 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; PYRAN COPOLYMER; STRONTIUM 89; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BONE MARROW; CELL INTERACTION; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; KUPFFER CELL; LIVER FUNCTION; LIVER PARENCHYMA; METASTASIS INHIBITION; MOBILIZATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNOLOGY;

EID: 0034083566     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.00014h.x     Document Type: Review

References (80)

1. 1. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975;16:216-229.
2. 2. Kiessling R, Klein E, Pross H, Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975;5:117-121.
3. 3. Pross HF, Jondal M. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol 1975;21:226-235.
4. 4. Timonen T, Saksela E. Isolation of human NK cells by density gradient centrifugation. J Immunol Methods 1980;36:285-291.
5. 5. Timonen T, Ortaldo JR, Herberman RB. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 1981;153:569-582.
6. 6. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
7. 7. Biron CA. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 1997;9:24-34.
8. 8. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
9. 9. Henney CS, Kuribayashi K, Kern DE, Gillis S. Interleukin-2 augments natural killer cell activity. Nature 1981;291:335-338.
10. 10. Welsh RM. Natural killer cells and interferon. Crit Rev Immunol 1986;5:55-93.
11. 11. Trinchieri G, Gerosa F. Immunoregulation by interleukin-12. J Leukoc Biol 1996;59:505-511.
12. 12. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999;17:19-49.
13. 13. Taub DD, Sayers TJ, Carter CR, Ortaldo JR. α-and β-chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995;155:3877-3888.
14. 14. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986;319:675-678.
15. 15. Lanier LL. Natural killer cells: from no receptors to too many. Immunity 1997;6:371-378.
16. 16. Lanier LL. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 1998;92:705-707.
17. 17. Wiltrout RH, et al. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 1984;160:1431-1449.
18. 18. Talmadge JE, et al. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2. J Immunol 1985;135:2483-2491.
19. 19. Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol 1996;156:4707-4714.
20. 20. Fogler WE, et al. Recruitment of hepatic NK cells by IL-12 is dependent on IFN-γ and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas. J Immunol 1998;161:6014-6021.
21. 21. Wiltrout RH, Talmadge JE, Herberman RB. Role of NK cells in prevention and treatment of metastases by biological response modifiers. In: Herberman RB, Wiltrout RH, Gorelik E. Immune responses to metastases. Vol II. Boca Raton: CRC Press; 1987. p. 25-41.
22. 22. Talmadge JE, Phillips H, Schindler J, Tribble H, Pennington R. Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease. Cancer Res 1987;47:5725-5732.
23. 23. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998;70:83-243.
24. 24. Wiltrout RH, et al. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 1985;134:4267-4275.
25. 25. Kaneda K, Dan C, Wake K. Pit cells as natural killer cells. Biomed Res 1983;4:567-576.
26. 26. Wisse E, van't Noordende JM, van der Meulen J, Daems WT. The pit cell: description of anew type of cell occurring in rat liver sinusoids and peripheral blood. Cell Tissue Res 1976;173:423-435.
27. + cells: new clues to their origin, specificity, and function. J Exp Med 1995;182:633-638.
28. 28. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-562.
29. 29. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3eps. Immunity 1998;9:345-353.
30. - T cells in mice and humans. J Exp Med 1994;180:1097-1106.
31. + cells. J Immunol 1998;160:1158-1165.
32. - thymocytes with specific lymphokine secretion. Eur J Immunol 1993;23:307-310.
33. + T cells upon NKR-P1 cross-linking. J Exp Med 1996;183:2391-2396.
34. + αβ T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 1996;156:2436-2442.
35. + αβ T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol 1995;154:4333-4340.
36. 14 NKT cells in IL-12-mediated rejection of tumors. Science 1997;278:1623-1626.
37. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999;163:2314-2321.
38. + T cells preferentially accumulate in human liver. Eur J Immunol 1999;29:2406-2413.
39. 39. Wisse E, Luo D, Vermijlen D, Kanellopoulou C, DeZanger R, Bracet F. On the function of pit cells, the liver specific natural killer cells. Semin Liver Dis 1997;17:265-286.
40. 40. Kaneda K, et al. Quantitative analysis of rod-cored vesicles and dense granules of large granular lymphocytes in the liver, spleen, and peripheral blood of rats. Cell Tissue Res 1994;276:187-195.
41. 41. Kaneda K, et al. Rod-cored vesicles in large granular lymphocyte (LGL) leukemia cells of rats: alterations induced followed metastasis in the liver. Biomed Res 1999;17:53-65.
42. + T cells in IL-12-induced immune responses in vivo. J Immunol 1998;160:16-19.
43. 43. Talmadge JE, Schneider M, Collins M, Phillips H, Herberman RB, Wiltrout RH. Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE. J Immunol 1985;135:1477-1483.
44. 44. Wiltrout RH, Salup RR, Twilley TA, Talmadge JE. Immunomodulation of natural killer activity by polyribonucleotides. J Biol Response Mod 1985;4:512-517.
45. 45. Wiltrout RH, Denn AC, III, Reynolds CW. Augmentation of organ-associated NK activity by BRMs: association of NK activity with mononuclear cell infiltration. Pathol Immunopathol Res 1986;5:219-233.
46. 46. Wiltrout RH, et al. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. J Immunol 1989;143:372-378.
47. 47. Biron CA, Young HA, Kasaian MT. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J Exp Med 1990;171:173-188.
48. 48. Carson WE, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395-1403.
49. 49. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
50. 50. Salazar-Mather TP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1-α (MIP-1α)-dependent pathways. J Exp Med 1998;187:1-14.
51. 51. Pilaro AM, et al. TNF-α is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J Immunol 1994;153:333-342.
52. 52. Smyth MJ, et al. Perform is a major contributor to NK cell control of tumor metastasis. J Immunol 1999;162:6658-6662.
53. + NKT cells. J Immunol 1999;162:5094-5098.
54. 54. Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, MacDonald HR. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol 1999;162:6410-6419.
55. 55. Lafreniere R, Rosenberg SA. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. J Immunol 1985;135:4273-4280.
56. + αβ-T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol 1996;156:3366-3373.
57. 57. Siders WM, et al. T-cell and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12 expressing recombinant adenovirus. J Immunol 1998;160:5465-5474.
58. 58. Watanabe M, et al. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production. J Immunol 1999;163:1943-1950.
59. + T lymphocytes. Eur J Immunol 1997;27:183-188.
60. + T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol 1997;159:97-106.
61. + T cells for liver injury induced by Salmonella infection in mice. Hepatology 1999;29:1799-1808.
62. 62. Wigginton JM, Komschlies KL, Back TC, Franco JL, Brunda MJ, Wiltrout RH. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J Natl Cancer Inst 1996;88:38-43.
63. 63. Carson WE, et al. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 1999;162:4943-4951.
64. 64. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996;272:50-53.
65. 65. Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB. Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer 1982;30:107-112.
66. 66. Salup RR, Herberman RB, Wiltrout RH. Role of natural killer activity in development of spontaneous metastases in murine renal cancer. J Urol 1985;134:1236-1241.
67. 67. Zhang SR, et al. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2. Cancer Immunol Immunother 1986;21:19-25.
68. 68. Mule JJ, Yang J, Shu S, Rosenberg SA. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. J Immunol 1986;136:3899-3909.
69. 69. Salup RR, Mathieson BJ, Wiltrout RH. Precursor phenotype of lymphokine-activated killer cells in the mouse. J Immunol 1987;138:3635-3639.
70. 70. Peron JM, Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR. FLT3-ligand administration inhibits liver metastases: role of NK cells. J Immunol 1998;161:6164-6170.
71. 71. Fernandez NC, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999;5:405-411.
72. - subsets, using Fas ligand/Fas molecules. Immunology 1997;91:219-226.
73. 73. Sayers TJ, et al. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. J Immunol 1998;161:3957-3965.
74. 74. Vermijlen D, Luo D, Robaye B, Seynaeve C, Baekeland M, Wisse E. Pit cells (hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway. Hepatology 1999;29:51-56.
75. 75. Kodama T, et al. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12. Eur J Immunol 1999;29:1390-1396.
76. 76. Kayagaki N, et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 1999;163:1906-1913.
77. 77. Ito D, Back TC, Shakhov AN, Wiltrout RH, Nedospasov SA. Mice with a targeted mutation in lymphotoxin-α exhibit enhanced tumor growth and metastasis: impaired NK cell development and recruitment. J Immunol 1999;163:2809-2815.
78. 78. Smyth MJ, et al. Multiple deficiencies underlie NK cell inactivity in lymphotoxin-α gene-targeted mice. J Immunol 1999;163:1350-1353.
79. 79. Yao L, Sgadari C, Furuke K, Bloom ET, Teruya Feldstein J, Tosato G. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood 1999;93:1612-1621.
80. 80. Eberl G, Lowin-Kropf B, MacDonald HR. Cutting edge: NKT cell development is selectively impaired in fyn-deficient mice. J Immunol 1999;163:4091-4094.